Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Several possible studies

Story checked

Research advances understanding of tick-borne Powassan virus (opens in a new tab)

medicalxpress.com · 2026-09-25

Short answerEvidenceSource

Short answer

Several possible studies

No clear answer.

More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Several studies could be the source of this story.

More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.

Open claim evidence
3

Search result

Several studies could fit.

More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.

Source paper

Source layer

The 5 papers the story cites

Source study separated from background citations.

The research anchor for the report.

Related research

Research nearby

The papers it could be

Nearby papers when the source is unclear.

and 38 more considered

Then inspect each claim

Evidence layer

Claim by claim

What the story asserts. With no source study, there is nothing to check these against.

Claim 1 of 6Not checkedPowassan virus is a rare but increasingly reported tick-borne infection that can cause severe brain inflammation and lasting neurological complications.View evidenceHide evidence

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 2 of 6Not checkedGeorgia State University researchers are helping fill knowledge gaps with three recent studies on Powassan virus, including new laboratory models, immune defense findings, and brain changes that could point to future treatments.View evidenceHide evidence

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 3 of 6Not checkedIn a study published in Viruses, the team found that brain microRNAs were widely disrupted during Powassan virus infection and were associated with inflammation, cell death, immune regulation and tissue repair pathways.View evidenceHide evidence

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 4 of 6Not checkedIn a study published in Frontiers in Immunology, the researchers developed an animal model that closely mirrors many neurological features of human Powassan virus infection and showed that the virus crosses the blood-brain barrier, triggers neuroinflammation, damages neurons and can persist in the brain long after initial infection.View evidenceHide evidence

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 5 of 6Not checkedIn a study published in Frontiers in Microbiology, the article says type I interferon is a key immune defense against Powassan virus, and when that pathway is disrupted the virus spreads rapidly and causes excessive inflammation in preclinical models.View evidenceHide evidence

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 6 of 6Not checkedThe article says the findings could help identify biomarkers, future treatment targets, and a foundation for testing antiviral therapies and other therapeutic strategies.View evidenceHide evidence

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Finally, the search trail

Method layer

No single source study was found.

NewsLink still surfaces nearby research so you can inspect the field instead of a single paper.

Nearby research

No exact source, but these papers are close.

PubMed, Europe PMC, Crossref · 37 candidate papers

And 32 more candidates considered.